Literature DB >> 25546786

Intravenous immunoglobulin G in the treatment of autoimmune bullous disease.

A Czernik1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25546786      PMCID: PMC4285515          DOI: 10.1111/cei.12535

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  4 in total

1.  Effect of intravenous immunoglobulin with or without cytotoxic drugs on pemphigus intercellular antibodies.

Authors:  Margarita Lolis; Siavash Toosi; Annette Czernik; Jean-Claude Bystryn
Journal:  J Am Acad Dermatol       Date:  2010-08-07       Impact factor: 11.527

2.  Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents: marked improvement in depletion of circulating autoantibodies.

Authors:  Annette Czernik; Jean-Claude Bystryn
Journal:  Arch Dermatol       Date:  2008-05

3.  IVIg selectively and rapidly decreases circulating pathogenic autoantibodies in pemphigus vulgaris.

Authors:  Jean-Claude Bystryn; Diane Jiao
Journal:  Autoimmunity       Date:  2006-11       Impact factor: 2.815

4.  A randomized double-blind trial of intravenous immunoglobulin for pemphigus.

Authors:  Masayuki Amagai; Shigaku Ikeda; Hiroshi Shimizu; Hajime Iizuka; Katsumi Hanada; Setsuya Aiba; Fumio Kaneko; Seiichi Izaki; Kunihiko Tamaki; Zenro Ikezawa; Masahiro Takigawa; Mariko Seishima; Toshihiro Tanaka; Yoshiki Miyachi; Ichiro Katayama; Yuji Horiguchi; Sachiko Miyagawa; Fukumi Furukawa; Keiji Iwatsuki; Michihiro Hide; Yoshiki Tokura; Masutaka Furue; Takashi Hashimoto; Hironobu Ihn; Sakuhei Fujiwara; Takeji Nishikawa; Hideoki Ogawa; Yasuo Kitajima; Koji Hashimoto
Journal:  J Am Acad Dermatol       Date:  2009-04       Impact factor: 11.527

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.